Compound Detail
CHEMBL4531226
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4531226 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AGHYWROLEMGBLK-UHFFFAOYSA-N |
4
Targets
6
Activities
2
Assay Types
3
PK Parameters
6
Publications
0
Known Names
Molecular Properties
517.6
MW (Da)
4.40
ALogP
9
HBA
2
HBD
78.4
PSA (Ų)
0.39
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 4 meas. best 5.97
IC50 2 meas. best 8.44
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| cGMP-dependent protein kinase CHEMBL2169724 | IC50 | 8.44 | 8.44 | 3.6 | 1 |
| Plasmodium falciparum CHEMBL364 | EC50 | 5.97 | 5.9033 | 1070.0 | 3 |
| L929 CHEMBL612267 | EC50 | 5.48 | 5.48 | 3300.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.27 | 5.27 | 5400.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.48 | mL.min-1.g-1 | Mus musculus |
| CL | 0.59 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 0.4 | mL.min-1.g-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| cGMP-dependent protein kinase | IC50 | = | 3.6 | nM | 8.44 | Inhibition of Plasmodium falciparum full length N-terminal His-tagged PKG expres... | 31566384 |
| Plasmodium falciparum | EC50 | = | 1070.0 | nM | 5.97 | Antiplasmodial activity against asexual form of Plasmodium falciparum NF54 asses... | 31566384 |
| Plasmodium falciparum | EC50 | = | 1120.0 | nM | 5.95 | Antiplasmodial activity against asexual form of Plasmodium falciparum NF54 asses... | 31566384 |
| Plasmodium falciparum | EC50 | = | 1620.0 | nM | 5.79 | Antiplasmodial activity against Plasmodium falciparum 3D7A erythrocytic stage as... | 31566384 |
| L929 | EC50 | = | 3300.0 | nM | 5.48 | Cytotoxicity against mouse L929 cells assessed as reduction in viability by dual... | 31566384 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 5400.0 | nM | 5.27 | Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay | 31566384 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31566384 | 10.1021/acs.jmedchem.9b01099 | Plasmodium falciparum | 3 |
| 31566384 | 10.1021/acs.jmedchem.9b01099 | No relevant target | 3 |
| 31566384 | 10.1021/acs.jmedchem.9b01099 | ADMET | 3 |
| 31566384 | 10.1021/acs.jmedchem.9b01099 | cGMP-dependent protein kinase | 1 |
| 31566384 | 10.1021/acs.jmedchem.9b01099 | L929 | 1 |
| 31566384 | 10.1021/acs.jmedchem.9b01099 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine